High degree of prostate related LUTS in a prospective cross-sectional community study in Ghana (Mamprobi)

被引:3
作者
Asare, George A. [1 ]
Sule, Derick S. [2 ]
Oblitey, Jared N. [2 ]
Ntiforo, Reese [2 ]
Asiedu, Bernice [1 ]
Amoah, Brodrick Y. [1 ]
Lamptey, Emmanuel L. [2 ]
Afriyie, Daniel K. [3 ]
Botwe, Benard Ohene [2 ]
机构
[1] Univ Ghana, Sch Biomed & Allied Hlth Sci SBAHS, Dept Med Lab Sci, Chem Pathol Unit, POB KB 143,Korle Bu Campus, Korle Bu, Ghana
[2] Univ Ghana, Sch Biomed & Allied Hlth Sci SBAHS, Dept Radiog, POB KB 143,Korle Bu Campus, Korle Bu, Ghana
[3] Ghana Police Hosp, Dept Pharm, Cantonments, Accra, Ghana
关键词
Lower urinary tract symptoms (LUTS); Benign prostatic hyperplasia (BPH); Prostate volume; Metabolic syndrome (MetS); URINARY-TRACT SYMPTOMS; METABOLIC SYNDROME; HYPERPLASIA BPH; MEN; ASSOCIATION; PREVALENCE; RISK; ENLARGEMENT; PROGRESSION; STORAGE;
D O I
10.1016/j.heliyon.2021.e08391
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Changing voiding patterns, volume and frequency, may sometimes be mistaken for anxiety, stress or increase in fluid consumption. In the aging male population, the commencement of lower urinary tract symptoms (LUTS) may be silent and perceived as "normal" and unrelated to Benign prostatic enlargement (BPE). The purpose of the study was to determine the prevalence of apparently "silent LUTS" (perceived asymptomatic LUTS) in men in a Ghanaian Community as well as its underlying risk factors. Methods: One hundred and eleven (111) men (40-70 years) were recruited from a community in Ghana. The International Prostate Symptoms Score (IPSS) questionnaire (administered in the local language and English) and ultrasonographic imaging of the prostate volume (PV) were utlized to collect data. IPSS score >7 plus PV > 30 cm3 was definitive of lower urinary tract symptoms. Eighty-one (81) participants were classified "LUTS Negative" (LN) and 30, "LUTS Positive" (LP). Risk factors i.e., cholesterol (CHOL), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), very low-density lipoprotein (VLDL), coronary risk (CR), BMI and Blood Pressure were also determined. Results: The prevalence of LUTS using only IPSS definition alone was 42.3%. However, IPSS in combination with Prostate Volume gave a prevalence of 27.0%. LN subjects had enlarged prostate (41.98%) and LP, 100%. Quality of life (QoL) was better in the LUTS Negative than LUTS Positive group (p < 0.001). In the univariant analysis coronary risk, triglyceride and VLDL contributed to LUTS (p = 0.023, 0.22, 0.22, respectively). In a multivariant analysis HDL-C (p = 0.027), BMI (p = 0.047) and triglyceride (p = 0.019) significantly contributed to LUTS. Conclusions: The prevalence of LUTS (42.3%) is high. Components of Metabolic Syndrome- HDL-C, BMI, and coronary risk were associated with LUTS. This emphasizes the need for community education.
引用
收藏
页数:8
相关论文
共 34 条
[1]  
Aboah K., 2016, INT J RES MED SCI, V4
[2]  
Aguilar-Salinas Carlos A, 2019, F1000Res, V8, DOI 10.12688/f1000research.17122.1
[3]   Prevalence estimates for lower urinary tract symptom severity among men in Uganda and sub-Saharan Africa based on regional prevalence data [J].
Bajunirwe, Francis ;
Stothers, Lynn ;
Berkowitz, Jonathan ;
Macnab, Andrew J. .
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (11) :E447-E452
[4]   THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J].
BERRY, SJ ;
COFFEY, DS ;
WALSH, PC ;
EWING, LL .
JOURNAL OF UROLOGY, 1984, 132 (03) :474-479
[5]   The association between triglyceride high density lipoprotein cholesterol ratio and benign prostate hyperplasia in non-diabetic patients:a cross-sectional study [J].
Besiroglu, Huseyin ;
Dursun, Murat ;
Otunctemur, Alper ;
Ozbek, Emin .
AGING MALE, 2017, 20 (03) :198-204
[6]   Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care, Port Harcourt, Nigeria [J].
Bock-Oruma, A. A. ;
Dienye, P. O. ;
Oghu, I. S. .
SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (05) :467-472
[7]   Prevalence of BPH and lower urinary tract symptoms in West Africans [J].
Chokkalingam, A. P. ;
Yeboah, E. D. ;
DeMarzo, A. ;
Netto, G. ;
Yu, K. ;
Biritwum, R. B. ;
Tettey, Y. ;
Adjei, A. ;
Jadallah, S. ;
Li, Y. ;
Chu, L. W. ;
Chia, D. ;
Niwa, S. ;
Partin, A. ;
Thompson, I. M. ;
Roehrborn, C. ;
Hoover, R. N. ;
Hsing, A. W. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (02) :170-176
[8]   Metabolic Syndrome and Lower Urinary Tract Symptoms in Patients With Benign Prostatic Enlargement: A Possible Link to Storage Symptoms [J].
De Nunzio, Cosimo ;
Cindolo, Luca ;
Gacci, Mauro ;
Pellegrini, Fabrizio ;
Carini, Marco ;
Lombardo, Riccardo ;
Franco, Giorgio ;
Tubaro, Andrea .
UROLOGY, 2014, 84 (05) :1181-1187
[9]   Sympathetic nerve biology in essential hypertension [J].
Esler, M ;
Rumantir, M ;
Kaye, D ;
Jennings, G ;
Hastings, J ;
Socratous, F ;
Lambert, G .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2001, 28 (12) :986-989
[10]   Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study [J].
Feng, Tom ;
Howard, Lauren E. ;
Vidal, Adriana C. ;
Moreira, Daniel M. ;
Castro-Santamaria, Ramiro ;
Andriole, Gerald L. ;
Freedland, Stephen J. .
INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (02) :151-156